A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer
Clinical trial NCT03258034 · UNKNOWN
Trial details
- NCT number
- NCT03258034
- Sponsor
- The First Affiliated Hospital of Zhejiang Chinese Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-24
- Primary completion
- 2020-08-22
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.